Riken To Attempt Replication Of Controversial STAP Stem Cell Work
This article was originally published in PharmAsia News
Executive Summary
The Riken institute in Japan has decided to attempt to start from the beginning and replicate the controversial research work that led to claims of stimulus-triggered acquisition of pluripotency.